Y-90-DOTATOC

· European Institute of Oncology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Y-90-DOTATOC, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant PRRT With Y-90-DOTATOC in pNET [Phase 2]